News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Yao-Yu Wu, MD

Articles by Yao-Yu Wu, MD

Although surgery and radiotherapy are standard treatments for localized STS, the role of adjuvant chemotherapy, particularly doxorubicin, in high-grade STS is debated.

Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study

ByShiny Chih-Hsuan Wu, MD,Yao-Yu Wu, MD,Chi-Ting Liau, MD,Chih‑Hsiang Chang, MD,Shih-Chiang Huang, MD,Hsin‑Nung Shih, MD,Chun-Chieh Chen, MD, PhD

March 26th 2026

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers

Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC

Nadofaragene Firadenovec Label Update Approved in BCG-Unresponsive NMIBC

IMNN-001 Plus Neoadjuvant Chemo Improves OS in Advanced Ovarian Cancer

When To Consider a Re-Biopsy in the Metastatic CRPC Treatment Course